LifeMD (LFMD) Competitors

$7.77
+0.05 (+0.65%)
(As of 05/17/2024 ET)

LFMD vs. AUNA, WGS, ZJYL, PACB, ALEC, STTK, ANL, OCS, PROK, and TVTX

Should you be buying LifeMD stock or one of its competitors? The main competitors of LifeMD include Auna (AUNA), GeneDx (WGS), Jin Medical International (ZJYL), Pacific Biosciences of California (PACB), Alector (ALEC), Shattuck Labs (STTK), Adlai Nortye (ANL), Oculis (OCS), ProKidney (PROK), and Travere Therapeutics (TVTX). These companies are all part of the "medical" sector.

LifeMD vs.

Auna (NYSE:AUNA) and LifeMD (NASDAQ:LFMD) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, media sentiment, earnings, institutional ownership, community ranking, risk, analyst recommendations and valuation.

Auna presently has a consensus target price of $14.15, indicating a potential upside of 62.27%. LifeMD has a consensus target price of $11.60, indicating a potential upside of 49.29%. Given LifeMD's higher possible upside, analysts plainly believe Auna is more favorable than LifeMD.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Auna
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
3.00
LifeMD
0 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
3.00

35.5% of LifeMD shares are owned by institutional investors. 18.9% of LifeMD shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

LifeMD received 22 more outperform votes than Auna when rated by MarketBeat users. However, 100.00% of users gave Auna an outperform vote while only 70.27% of users gave LifeMD an outperform vote.

CompanyUnderperformOutperform
AunaOutperform Votes
4
100.00%
Underperform Votes
No Votes
LifeMDOutperform Votes
26
70.27%
Underperform Votes
11
29.73%

In the previous week, LifeMD had 1 more articles in the media than Auna. MarketBeat recorded 4 mentions for LifeMD and 3 mentions for Auna. Auna's average media sentiment score of 0.44 beat LifeMD's score of 0.20 indicating that LifeMD is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Auna
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
LifeMD
1 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Auna has a net margin of 0.00% compared to Auna's net margin of -14.75%.

Company Net Margins Return on Equity Return on Assets
AunaN/A N/A N/A
LifeMD -14.75%N/A -49.23%

Auna has higher earnings, but lower revenue than LifeMD.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AunaN/AN/AN/AN/AN/A
LifeMD$152.55M2.15-$20.60M-$0.74-10.50

Summary

LifeMD beats Auna on 7 of the 11 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LFMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LFMD vs. The Competition

MetricLifeMDOffices & clinics of medical doctors IndustryMedical SectorNASDAQ Exchange
Market Cap$328.59M$672.46M$5.09B$7.94B
Dividend YieldN/AN/A37.18%3.91%
P/E Ratio-10.5038.83179.5718.75
Price / Sales2.151.182,342.7687.73
Price / CashN/A71.5836.2632.08
Price / Book259.0039.205.724.68
Net Income-$20.60M-$189.18M$105.03M$217.01M
7 Day Performance-16.63%-1.03%1.90%2.93%
1 Month Performance-21.28%-10.77%4.21%6.22%
1 Year Performance315.51%14.25%6.45%9.80%

LifeMD Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AUNA
Auna
0 of 5 stars
$6.67
-0.7%
$14.15
+112.1%
N/A$493.05MN/A0.0014,958Upcoming Earnings
WGS
GeneDx
1.4201 of 5 stars
$19.29
-1.2%
$18.00
-6.7%
+280.7%$503.86M$202.57M-3.721,000Insider Buying
Positive News
ZJYL
Jin Medical International
0 of 5 stars
$3.25
-10.0%
N/A-41.4%$503.75MN/A0.00269Positive News
PACB
Pacific Biosciences of California
2.6833 of 5 stars
$1.87
-6.0%
$7.77
+315.7%
-82.1%$509.28M$200.52M-1.55796Analyst Upgrade
Analyst Revision
ALEC
Alector
3.4414 of 5 stars
$5.30
-0.4%
$14.86
+180.3%
-27.9%$510.87M$97.06M-3.42244Short Interest ↑
STTK
Shattuck Labs
2.4265 of 5 stars
$10.75
-3.8%
$20.00
+86.0%
+195.8%$511.16M$1.66M-5.5775Analyst Forecast
ANL
Adlai Nortye
1.0353 of 5 stars
$13.57
+6.6%
$30.00
+121.1%
N/A$500.73MN/A0.00127Positive News
Gap Down
OCS
Oculis
1.1599 of 5 stars
$12.64
-0.6%
$29.14
+130.6%
+3.5%$511.92M$980,000.000.0036Analyst Revision
PROK
ProKidney
2.5921 of 5 stars
$2.39
+6.7%
$9.50
+297.5%
-61.0%$513.73MN/A-4.19163
TVTX
Travere Therapeutics
1.079 of 5 stars
$6.75
+3.1%
$16.69
+147.3%
-59.4%$513.74M$145.24M-4.19380Gap Up

Related Companies and Tools

This page (NASDAQ:LFMD) was last updated on 5/17/2024 by MarketBeat.com Staff

From Our Partners